drugset / Trial / NCT01068626
Rosuvastatin in Visceral Adiposity
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate whether 6 months treatment with the cholesterol-lowering drug rosuvastatin may reduce visceral fat tissue in obese middle aged men.
Timeline
- Start
- 2006-05
- Primary completion
- 2008-10
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rosuvastatin | Small molecule | 10 mg | — |